A team of researchers mapping a molecular atlas for ductal carcinoma in situ (DCIS) has made a major advance toward distinguishing whether the early pre-cancers in the breast will develop into invasive cancers or remain stable.
Amid the AI gold rush, a new company forms to vet models and root out weaknesses
The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But
June 21, 2023